SA’s medicines regulator has authorised five new Covid-19 antibody tests, which will help doctors retrospectively diagnose patients and provide a vital research tool for local vaccine trials.

The SA Health Products Regulatory Authority (Sahpra) announced on Monday that it had issued section 21 authorisation for laboratory-based antibody tests manufactured by Abbott Laboratories SA, Roche Diagnostics and Euroimmun Medical Laboratory Diagnostics SA. It has also authorised seven licence holders of Zhejiang Orient Gene Biotech’s rapid point of care antibody test...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now